117 related articles for article (PubMed ID: 10480585)
21. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
23. Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn.
Tan ND; Davidson D
Pediatr Res; 1995 Jul; 38(1):11-6. PubMed ID: 7478787
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism.
Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC
J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415
[TBL] [Abstract][Full Text] [Related]
25. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
27. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
28. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases.
Thakur A; Willcox MD
Exp Eye Res; 1998 Jul; 67(1):9-19. PubMed ID: 9702174
[TBL] [Abstract][Full Text] [Related]
29. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
30. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.
Faccioli LH; Nourshargh S; Moqbel R; Williams FM; Sehmi R; Kay AB; Williams TJ
Immunology; 1991 Jun; 73(2):222-7. PubMed ID: 1649126
[TBL] [Abstract][Full Text] [Related]
31. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
32. The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.
Moqbel R; Walsh GM; Nagakura T; MacDonald AJ; Wardlaw AJ; Iikura Y; Kay AB
Immunology; 1990 Jun; 70(2):251-7. PubMed ID: 2373521
[TBL] [Abstract][Full Text] [Related]
33. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).
Sigal CE; Valone FH; Holtzman MJ; Goetzl EJ
J Clin Immunol; 1987 Mar; 7(2):179-84. PubMed ID: 3571436
[TBL] [Abstract][Full Text] [Related]
34. Changes of cytosolic calcium ion concentrations in human endothelial cells in response to thrombin, platelet-activating factor, and leukotriene B4.
Lerner R
J Lab Clin Med; 1994 Nov; 124(5):723-9. PubMed ID: 7964131
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
Kimani G; Tonnesen MG; Henson PM
J Immunol; 1988 May; 140(9):3161-6. PubMed ID: 3361129
[TBL] [Abstract][Full Text] [Related]
36. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
McEwen BJ; Wilcock BP; Eyre P
Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
[TBL] [Abstract][Full Text] [Related]
37. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
Coëffier E; Joseph D; Vargaftig BB
Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two modified techniques for purifying blood eosinophils.
Laviolette M; Bossé M; Rocheleau H; Lavigne S; Ferland C
J Immunol Methods; 1993 Oct; 165(2):253-61. PubMed ID: 8228275
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4.
Czarnetzki BM; Csatò M
Int Arch Allergy Appl Immunol; 1989; 88(1-2):191-3. PubMed ID: 2540094
[TBL] [Abstract][Full Text] [Related]
40. New method for the measurement of eosinophil migration.
Håkansson L; Westerlund D; Venge P
J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
